Why Would Enveric Do This?The potential in this is extraordinary for both companies.
I would expect that the reasons for Enteric entering into an agreement like this is that they have a much faster path to clinical trials for their patented drugs and system. By the time they could get FDA approval MBIO could be on to the second phase of trials.
As for MBIO the most significant challenge would be cash to carry out trials for a different drug candidate. The fact that they're expressing payback through royalties etc in the $60+ million range suggests there is strong belief in the relationship.
As for the cash buyout ...does it refer to the potential for MBIO to ultimately buy out Enteric? It looks to me like Justin and the rest of the Board of MBIO has their hands solidly on the wheel.
Regardless, this is the kind of exponential development seen in this clinical trials stage of MBIO.